Metformin decreases the incidence of ovarian hyperstimulation syndrome: an experimental studyReport as inadecuate




Metformin decreases the incidence of ovarian hyperstimulation syndrome: an experimental study - Download this document for free, or read online. Document in PDF available to download.

Journal of Ovarian Research

, 6:62

First Online: 08 September 2013Received: 01 June 2013Accepted: 31 August 2013

Abstract

BackgroundIn assisted reproduction cycles, gonadotropins are administered to obtain a greater number of oocytes. A majority of patients do not have an adverse response; however, approximately 3-6% develop ovarian hyperstimulation syndrome OHSS. Metformin reduces the risk of OHSS but little is known about the possible effects and mechanisms of action involved.

ObjectiveTo evaluate whether metformin attenuates some of the ovarian adverse effects caused by OHSS and to study the mechanisms involved.

Material and methodsA rat OHSS model was used to investigate the effects of metformin administration. Ovarian histology and follicle counting were performed in ovarian sections stained with Masson trichrome. Vascular permeability was measured by the release of intravenously injected Evans Blue dye EB. VEGF levels were measured by commercially immunosorbent assay kit. COX-2 protein expression was evaluated by western blot and NOS levels were analyses by immunohistochemistry.

ResultsAnimals of the OHSS group showed similar physiopathology characteristics to the human syndrome: increased body weight, elevated progesterone and estradiol levels P<0.001, increased number of corpora lutea P<0.001, higher ovarian VEGF levels and vascular permeability P<0.001 and P<0.01; and treatment with metformin prevented this effect OHSS+M group; P<0.05. The vasoactive factors: COX-2 and NOS were increased in the ovaries of the OHSS group P<0.05 and P<0.01 and metformin normalized their expression P<0.05; suggesting that metformin has a role preventing the increased in vascular permeability caused by the syndrome.

ConclusionMetformin has a beneficial effect preventing OHSS by reducing the increase in: body weight, circulating progesterone and estradiol and vascular permeability. These effects of metformin are mediated by inhibiting the increased of the vasoactive molecules: VEGF, COX-2 and partially NOS. Molecules that are increased in OHSS and are responsible for a variety of the symptoms related to OHSS.

Electronic supplementary materialThe online version of this article doi:10.1186-1757-2215-6-62 contains supplementary material, which is available to authorized users.

Download fulltext PDF



Author: Evelin M Elia - Ramiro Quintana - Carlos Carrere - María V Bazzano - Gastón Rey-Valzacchi - Dante A Paz - María C Pu

Source: https://link.springer.com/



DOWNLOAD PDF




Related documents